The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Progression-free survival and patterns of response in patients with high-risk neuroblastoma (HR-NB) treated with irinotecan/temozolomide/dinutuximab/granulocyte-macrophage colony-stimulating factor (I/T/DIN/GM-CSFS) chemoimmunotherapy.
 
Benjamin Lerman
No Relationships to Disclose
 
Yimei Li
No Relationships to Disclose
 
Meaghan Granger
No Relationships to Disclose
 
Thomas Cash
Honoraria - EUSA Pharma
Consulting or Advisory Role - Y-mAbs Therapeutics
Research Funding - Celgene; Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - Lilly; United Therapeutics
 
Arhanti Sadanand
No Relationships to Disclose
 
Katherine Somers
No Relationships to Disclose
 
Aeesha Ranavaya
No Relationships to Disclose
 
Michelle Choe
No Relationships to Disclose
 
Jennifer Foster
No Relationships to Disclose
 
Daniel A. Morgenstern
Honoraria - Ology Medical Education; PlatformQ Health; WebMD
Consulting or Advisory Role - Clarity Pharmaceuticals; EUSA Pharma; Ymabs Therapeutics Inc
Speakers' Bureau - Ymabs Therapeutics Inc
Research Funding - Abbvie (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cellectar (Inst); Lilly (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly
 
Margarida Simao Rafael
No Relationships to Disclose
 
Keri A. Streby
Consulting or Advisory Role - Amgen; Innervate RAdiopharmaceuticals; Ymabs Therapeutics Inc
Research Funding - United Therapeutics (Inst)
 
Rachel Zeno
No Relationships to Disclose
 
Rajen Mody
Consulting or Advisory Role - Amgen
 
Sahr Yazdani
No Relationships to Disclose
 
Ami Vijay Desai
Stock and Other Ownership Interests - Pfizer; Viatris
Consulting or Advisory Role - Ology Medical Education; Ymabs Therapeutics Inc
Research Funding - Actuate Therapeutics (Inst); GlaxoSmithKline (Inst); Jubilant DraxImage (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Ymabs Therapeutics Inc (Inst)
 
Margaret E Macy
Stock and Other Ownership Interests - GE Healthcare; Johnson & Johnson; Varian Medical Systems
Consulting or Advisory Role - Ymabs Therapeutics Inc
Research Funding - Abbvie (Inst); Actuate Therapeutics (Inst); Bayer (Inst); Ignyta (Inst); Jubilant DraxImage (Inst); Lilly (Inst); Merck (Inst); Oncternal Therapeutics, Inc (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent for non-invasive methods of leukemia cell detection with MRI/MRS - Patent No. 8894975
 
Suzanne Shusterman
Stock and Other Ownership Interests - Amgen (I); BioTelemetry (I); Bristol-Myers Squibb (I); Evofem (I); GlaxoSmithKline (I); Intuitive Surgical (I); InVitae (I); Kindred Biosciences (I); Merck (I); Nuvasive (I); OPKO Health (I); Regeneron (I); RTI Health Solutions (I); Surgalign (I)
 
Sara Michele Federico
No Relationships to Disclose
 
Rochelle Bagatell
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc